NAFTI-CT

This brand name is authorized in Germany

Active ingredients

The drug NAFTI-CT contains one active pharmaceutical ingredient (API):

1 Naftidrofuryl
UNII 5ADB8D9388 - NAFRONYL OXALATE

Naftidrofuryl oxalate is a powerful vasodilator agent with an antagonist effect on 5-HT2 receptors of the smooth muscle cells. The vasodilator effect, which occurs in both the cerebral and peripheral circulation, is probably the main action. It is claimed that this action protects cells against the metabolic effects of ischaemia.

Read about Naftidrofuryl

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
C04AX21 Naftidrofuryl C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AX Other peripheral vasodilators
Discover more medicines within C04AX21

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut fĂźr Arzneimittel und Medizinprodukte Identifier(s): 06877075

Š All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈